These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28423213)

  • 21. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
    Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
    Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
    Lee YL; Lee YJ; Ahn SJ; Choi TH; Moon BS; Cheon GJ; Lee SW; Ahn BC; Ha JH; Lee J
    Cancer Lett; 2010 Apr; 290(1):129-38. PubMed ID: 19819065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential usefulness of baculovirus-mediated sodium-iodide symporter reporter gene as non-invasively gene therapy monitoring in liver cancer cells: an in vitro evaluation.
    Pan Y; Wu H; Liu S; Zhou X; Yin H; Li B; Zhang Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):139-48. PubMed ID: 23919394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.
    Schug C; Sievert W; Urnauer S; Müller AM; Schmohl KA; Wechselberger A; Schwenk N; Lauber K; Schwaiger M; Multhoff G; Wagner E; Nelson PJ; Spitzweg C
    Hum Gene Ther; 2018 Nov; 29(11):1287-1300. PubMed ID: 29724129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Approach for Image-Guided
    Schug C; Gupta A; Urnauer S; Steiger K; Cheung PF; Neander C; Savvatakis K; Schmohl KA; Trajkovic-Arsic M; Schwenk N; Schwaiger M; Nelson PJ; Siveke JT; Spitzweg C
    Mol Cancer Res; 2019 Jan; 17(1):310-320. PubMed ID: 30224540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.
    Grünwald GK; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Göke B; Holm PS; Spitzweg C
    Gene Ther; 2013 Jun; 20(6):625-33. PubMed ID: 23038026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice.
    Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
    Gene Ther; 2006 Jan; 13(1):60-6. PubMed ID: 16121204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
    Huang R; Zhao Z; Ma X; Li S; Gong R; Kuang A
    Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
    Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
    Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS).
    Gaut AW; Niu G; Krager KJ; Graham MM; Trask DK; Domann FE
    Head Neck; 2004 Mar; 26(3):265-71. PubMed ID: 14999802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
    Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
    Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.
    Cho JY
    Curr Gene Ther; 2002 Dec; 2(4):393-402. PubMed ID: 12477251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
    Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
    Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
    Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
    Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.
    Boland A; Ricard M; Opolon P; Bidart JM; Yeh P; Filetti S; Schlumberger M; Perricaudet M
    Cancer Res; 2000 Jul; 60(13):3484-92. PubMed ID: 10910060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.